Literature DB >> 7808245

Endurance athletes' stroke volume does not plateau: major advantage is diastolic function.

N Gledhill1, D Cox, R Jamnik.   

Abstract

Left ventricular function was examined during incremental work rates to maximum using simultaneous determinations of stroke volume, left ventricular ejection time (LVET), and diastolic filling time (DT). Seven endurance trained and seven untrained young adult males were studied on a cycle ergometer at matched heart rates of 90, 120, 140, 160, 180, and 190 bpm (+/- 1 bpm). Stroke volume of the untrained subjects reached a plateau at 120 bpm, but stroke volume of the trained subjects continued to increase to their maximum heart rate with no plateau. Throughout incremental work rates, LVET was significantly longer and DT was significantly shorter in the trained subjects. At a heart rate of 190 bpm, the corresponding rates of ventricular emptying and ventricular filling of the trained versus the untrained subjects were 20% and 71% greater, respectively (P < 0.01). We conclude that during incremental work rates the stroke volume of endurance trained athletes increases progressively to maximum with no plateau. In addition, although trained athletes rely on enhancements in both ventricular filling and ventricular emptying to augment stroke volume, by far their major advantage over untrained subjects is in ventricular filling.

Entities:  

Mesh:

Year:  1994        PMID: 7808245

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  69 in total

1.  Heart dimensions may influence the occurrence of the heart rate deflection point in highly trained cyclists.

Authors:  A Lucía; A Carvajal; A Boraita; L Serratosa; J Hoyos; J L Chicharro
Journal:  Br J Sports Med       Date:  1999-12       Impact factor: 13.800

2.  Hemodynamics during active and passive recovery from a single bout of supramaximal exercise.

Authors:  Antonio Crisafulli; Valentina Orrù; Franco Melis; Filippo Tocco; Alberto Concu
Journal:  Eur J Appl Physiol       Date:  2003-03-04       Impact factor: 3.078

Review 3.  Endurance and strength training for soccer players: physiological considerations.

Authors:  Jan Hoff; Jan Helgerud
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  A new incremental test for VO₂max accurate measurement by increasing VO₂max plateau duration, allowing the investigation of its limiting factors.

Authors:  Hélène Petot; Renaud Meilland; Laurence Le Moyec; Laurence Mille-Hamard; Véronique L Billat
Journal:  Eur J Appl Physiol       Date:  2011-10-14       Impact factor: 3.078

Review 5.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 6.  Training to enhance the physiological determinants of long-distance running performance: can valid recommendations be given to runners and coaches based on current scientific knowledge?

Authors:  Adrian W Midgley; Lars R McNaughton; Andrew M Jones
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 7.  Is there an optimal training intensity for enhancing the maximal oxygen uptake of distance runners?: empirical research findings, current opinions, physiological rationale and practical recommendations.

Authors:  Adrian W Midgley; Lars R McNaughton; Michael Wilkinson
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 8.  Is it time to retire the 'central governor'?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 9.  Endurance athletes' stroke volume response to progressive exercise: a critical review.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

10.  Cardiac response to exercise in young, normal weight and overweight men and women.

Authors:  Chantal A Vella; Raul Y Zubia; Stephen F Burns; Diana Ontiveros
Journal:  Eur J Appl Physiol       Date:  2008-11-07       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.